Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nervenruh forte is a traditional herbal medicinal product used to alleviate symptoms of nervous tension and sleep disturbances. It is a fixed-dose combination containing dry extracts of valerian root (*Valeriana officinalis*), hops cones (*Humulus lupulus*), and passionflower herb (*Passiflora incarnata*). The drug's mechanism of action is primarily attributed to the modulation of the gamma-aminobutyric acid (GABA) system; constituents such as valerenic acid and various flavonoids act as positive allosteric modulators of GABA-A receptors, enhancing inhibitory neurotransmission in the central nervous system. Additionally, components from hops exhibit melatonin-like activity, further contributing to its sedative properties. Clinical research, notably conducted at the Medical University of Graz, has explored the efficacy of Nervenruh forte as a premedication to reduce perioperative anxiety and manage postoperative pain, positioning it as a natural alternative or adjunct to synthetic anxiolytics in surgical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nervenruh forte.